VA
Valneva SE
VALN · NASDAQ
$6.56 +0.15% (+$0.01)
1M -2.81%
Market Cap 541.7M €
P/E Ratio -
Div. Yield -
ROE 152.63%
Piotroski F-Score Weak
1/9Valuation
32 /100
Expensive P/B 6.68x
P/S 3.77x
PEG N/A
Growth
0 /100
Declining Book val. growth 21.54%
Rev. growth 21.52%
FCF growth N/A
Profitability
4 /100
Weak FCF margin 59.70%
Op. margin 80.93%
Gross margin 16.35%
Quality
5 /100
Poor Asset turnover 0.37x
ROA 40.75%
ROIC 37.97%
Debt
23 /100
High Current ratio 2.16x
Int. coverage -2.83x
Debt/Equity 2.59x
Stability
16 /100
Unstable Profitable years 0
EPS volatility 428.59%
Beta 1.35x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre VALN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Thomas Lingelbach
Employees
674
Headquarters
Saint-Herblain
Evenimente viitoare
19 NOV.
Earnings
Upcoming earnings report